Hydroxychloroquine as an add-on therapy for the induction therapy of MPO-AAV: a retrospective observational cohort study
HCQ together with standard induction treatment may improve the remission rate of MPO-AAV patients, and HCQ had good safety in our study.
Authors
- Ting Meng (ORCID: https://orcid.org/0009-0002-2296-9835)
- Hui Luo (ORCID: https://orcid.org/0000-0001-5593-8563)
- Joshua D. Ooi (ORCID: https://orcid.org/0000-0003-3328-2561)
- Xiangcheng Xiao (ORCID: https://orcid.org/0000-0003-2515-5503)
- Qi Xiong
- Xueling Hu (ORCID: https://orcid.org/0000-0003-0048-0967)
- Jinbiao Chen (ORCID: https://orcid.org/0000-0003-0339-5880)
- Yong Zhong (ORCID: https://orcid.org/0000-0003-2520-0087)
- Rong Tang (ORCID: https://orcid.org/0000-0001-5619-6047)
- Peter J. Eggenhuizen (ORCID: https://orcid.org/0000-0002-7102-3547)
- Ning Liu (ORCID: https://orcid.org/0000-0002-9487-9305)
- Jia Xu
- Wei Lin (ORCID: https://orcid.org/0009-0006-5068-4502)
- Ping Xiao (ORCID: https://orcid.org/0000-0002-1199-2602)
- Yaou Zhou
- Yizi Gong
Institutions
- Central South University (CN)
- Xiangya Hospital Central South University (CN)
- Monash University (AU)
Publication Details
- Journal
- Clinical Kidney Journal
- Published
- 2024-09-01
- DOI
- https://doi.org/10.1093/ckj/sfae264
- Citations
- 1
- Primary Topic
- Vasculitis and related conditions
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- Health Commission of Hunan Province
- Xiangya Hospital, Central South University